Table 7 Comparison of CR/PR and SD/PD efficacy in subgroups
| Â | Group 1 | Group 2 | Group 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
UX first-line therapy (n = 9) | Eri first-line therapy (n = 11) | P-value | UX second-line or above therapy (n = 31) | Eri second-line or above therapy (n = 28) | P-value | Eri first-line therapy (n = 11) | Eri second-line or above therapy (n = 28) | P-value | |
CR/PR | 3 | 3 | > 0.999 | 5 | 6 | 0.602 | 3 | 6 | 0.693 |
SD/PD | 6 | 8 | 26 | 22 | 8 | 22 | |||